Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;72(7):2249-2253.
doi: 10.1111/jgs.18894. Epub 2024 Mar 29.

The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: An exploratory study

Melanie J de Jong  1 , Hamza Saadan  2 , Dave L S Hellenbrand  1   3 , Hugo Ten Cate  1   4 , Bart Spaetgens  2   4 , Renée A G Brüggemann  2   4 , Sander M J van Kuijk  5 , Kristien Winckers  1   4 , Yvonne M C Henskens  1   3 , Fabienne J H Magdelijns  2   4
Affiliations

The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: An exploratory study

Melanie J de Jong et al. J Am Geriatr Soc. 2024 Jul.
No abstract available

PubMed Disclaimer

Similar articles

See all similar articles

References

REFERENCES

    1. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user‐friendly score (HAS‐BLED) to assess 1‐year risk of major bleeding in patients with atrial fibrillation: the euro heart survey. Chest. 2010;138(5):1093‐1100.
    1. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor‐based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263‐272.
    1. Connors JM. Testing and monitoring direct oral anticoagulants. Blood. 2018;132(19):2009‐2015.
    1. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163‐184.
    1. Joosten LPT, van Doorn S, van de Ven PM, et al. Safety of switching from a vitamin K antagonist to a non‐vitamin K antagonist Oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL‐AF randomized controlled trial. Circulation. 2023;149:279‐289.

LinkOut - more resources